NASDAQ: CAPR LAWSUIT ALERT: Investors who lost money with shares of Capricor Therapeutics, Inc.should contact the Shareholders Foundation

A securities lawsuit was filed against Capricor Therapeutics on July 30, 2026 by an investor in CAPR shares over alleged securities law violations, and the Shareholders Foundation is alerting shareholders with losses that a September 28, 2026 deadline applies. The complaint alleges Capricor adopted changes to the pre-specified statistical analysis plan for its lead asset Deramiocel without the FDA agreeing to those changes before the Biologics License Application resubmission, creating substantial risk the agency finds the clinical data insufficient to support approval in Duchenne muscular dystrophy.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.